Differences among techniques for high-abundant protein depletion

Proteomics

Volumn 5, Issue 13, 2005, Pages 3304-3313

  Zolotarjova, Nina ^a   Martosella, James ^a   Nicol, Gordon ^a   Bailey, Jerome ^a   Boyes, Barry E ^a   Barrett, William C ^a  

^a AGILENT TECHNOLOGIES   (United States)

Author keywords

Albumin; Immunodepletion; Multiple affinity; Protein depletion; Serum

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; ANGIOTENSIN; ANTITHROMBIN III; APOLIPOPROTEIN A1; BIOLOGICAL MARKER; CERULOPLASMIN; CIBACRON BLUE F3GA; CLUSTERIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C7; COMPLEMENT COMPONENT C9; CYTOKERATIN; GELSOLIN; HAPTOGLOBIN; HEMOPEXIN; HEPARIN COFACTOR II; IMMUNOGLOBULIN G; KININOGEN; PEPTIDOGLYCAN; POLYPEPTIDE; PREALBUMIN; PROTEOME; SERUM AMYLOID P; SOMATOMEDIN BINDING PROTEIN; TRIFLUOROETHANOL; TRYPSIN; TRYPSINOGEN; UNINDEXED DRUG;

AFFINITY CHROMATOGRAPHY; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEPLETION; PROTEOMICS; SERUM;

ALBUMINS; ANIMALS; BIOLOGICAL ASSAY; BIOLOGICAL MARKERS; BLOOD PROTEINS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOCHEMISTRY; IMMUNOGLOBULIN G; MASS SPECTROMETRY; PEPTIDES; PROTEOME; PROTEOMICS; TRIFLUOROETHANOL; TRYPSIN;

EID: 23944475619     PISSN: 16159853     EISSN: None     Source Type: Journal    
DOI: 10.1002/pmic.200402021     Document Type: Article

References (20)

1. Bodovitz, S., Joos, T., Trends Biotechnol. 2004, 22, 4-7.
2. Ilyin, S. E., Belkowski, S. M., Plata-Salamán, C. R., Trends Biotechnol. 2004, 22, 411-416.
3. Chromy, B. A, Gonzales, A. D., Perkins, J., Choi, M. W. et al., J. Proteome Res. 2004, 3, 1120-1127.
4. Maccarrone, G., Milfay, D., Birg, I., Rosenhagen, M. et al., Electrophoresis 2004, 25, 2402-2412.
5. Prestera, T., Prochaska, H. J., Talalay, P., Biochemistry 1992, 31, 824-833.
6. Thresher, W. C., Swaisgood, H. C., J. Mol. Recogn. 1990, 3, 220-228.
7. Zhang, W.-W., Drug Discov. Today 2003, 8, 364-371.
8. Hinerfeld, D., Innamorati, D., Pirro, J., Tam, S. W., J. Biomol. Techn. 2004, 15, 184-190.
9. Zolotarjova, N., Boyes, B., Martosella, J., Yang, L.-S. et al., in: Smejkal, G. B., Lazarev, A. (Eds.), Separation Methods in Proteomics, CRC Press, Boca Ratan, FL, 2005, in press.
10. Peiper, R., Su, Q., Gatlin, C. L., Huang, S.-T., Anderson, N. L., Steiner, S., Proteomics 2003, 3, 422-432.
11. Björhall, K., Miliotis, T., Davidsson, P., Proteomics 2005, 5, 307-317.
12. Echan, L. A., Tang, H.-Y., Ali-Khan, N., Lee, K., Speicher, D. W., Proteomics 2005, 5, DOI: 10.1002/pmic.200400518.
13. Yang, Z., Hancock, W. S., J. Chromatogr. A 2004, 1053, 79-88.
14. Bailey, J., Zhang, K., Zolotarjova, N., Nicol, G. et al., Genetic Eng. News 2003, 23, 32-37.
15. Szafranski, C., Bailey, J., Turck, C., Nicol, G. et al., Pharmagenomics 2004, September, 40-46.
16. Henry, J. B., Clinical Diagnosis and Management by Laboratory Methods, W. B. Saunders, Philadelphia, PA 1996, Chapter 11, pp. 237-252.
17. Zhou, M., Lucas, D. A., Chan, K. C., Issaq, H. J. et al., Electrophoresis 2004, 25, 1289-1298.
18. Ogata, Y., Charlesworth, M. C., Muddiman, D. C., J. Proteome Res. 2005, 4, 831-845.
19. Petricoin, E. F., Liotta, L. A., Curr. Opin. Biotechnol. 2004, 15, 24-30.
20. Martosella, J. D., Zolotarjova, N., Liu, H., Nicol, G. et al., J. Proteome Res. 2005, in press.